EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Targeting SPP 1‐ CD 44‐Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis

Atsushi Nara, Shu Shimada iD, Yoshimitsu Akiyama, Megumi Hatano, Yusuke Chino, Suguru Miyazawa, Hanako Tamura, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Shuichi Watanabe, Eriko Katsuta und 5 weitere

Cancer Science · 2025

DOI: 10.1111/cas.70296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Atsushi Nara und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Osteopontin, Hyaluronan Receptors. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology of Japan, The Princess Takamatsu Cancer Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced hepatic fibrosis is a major risk factor for cirrhosis and hepatocellular carcinoma (HCC), and it is required to identify a key mediator involved in intratumoral fibrosis and HCC development. Transcriptomic analysis of 372 HCC samples using publicly available datasets revealed that SPP1 was significantly upregulated in fibrotic HCC tissues and associated with unfavorable outcomes. Immunohistochemical analysis of 103 HCC tissues and single‐cell RNA sequencing (scRNA‐seq) analysis of 228,564 live cells identified SPP1 overexpression in HCC cells, which strongly correlated with intratumoral fibrosis. In xenograft models, HCC cells with SPP1 overexpression (SPP1‐OE) exhibited enhanced fibrosis and tumor growth. Coculture assay demonstrated that SPP1‐OE cells stimulated hepatic stellate cells (HSCs), and gene set enrichment analysis and differential gene expression analysis elucidated the activation of the Hedgehog signaling pathway and upregulation of GLI1 in HSCs. Cell–cell interaction prediction analysis using scRNA‐seq data suggested that SPP1‐CD44 signaling transduction might contribute to HSC activation. Pharmacological inhibition of GLI1 with the SMO inhibitor vismodegib suppressed HSC activation in vitro and reduced fibrosis and tumor growth in vivo. These findings indicate that SPP1 promotes intratumoral fibrosis and HCC progression through the SPP1‐CD44‐GLI1 axis, highlighting its potential as a prognostic biomarker and therapeutic target. Inhibition of SPP1‐CD44‐Hedgehog signaling may provide a promising strategy to mitigate fibrosis and improve HCC patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsOsteopontinHyaluronan ReceptorsHedgehog ProteinsLiver CirrhosisHumansAnimalsMiceHepatic Stellate CellsSignal TransductionCell Line, TumorMaleXenograft Model Antitumor AssaysFemaleGene Expression Regulation, NeoplasticMice, Nude

Stichwörter der Autor:innen

CD44SPP1hedgehoghepatic stellate cellsintratumoral fibrosis

Substanzen

OsteopontinSPP1 protein, humanHyaluronan ReceptorsHedgehog ProteinsCD44 protein, human

Autor:innen und Institutionen

  • Department of Molecular Oncology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Human Pathology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan.

ORCID-Profile: Shu Shimada, Shinji Tanaka

Förderung

  • Japan Agency for Medical Research and Development
  • Ministry of Education, Culture, Sports, Science and Technology of Japan
  • The Princess Takamatsu Cancer Research Fund

Zitieren

APA

Nara, A., Shimada, S., Akiyama, Y., Hatano, M., Chino, Y., Miyazawa, S., Tamura, H., Asano, D., Ishikawa, Y., Ueda, H., Watanabe, S., Katsuta, E., Akahoshi, K., Ohashi, K., Tanabe, M., Ban, D., & Tanaka, S. (2025). Targeting SPP 1‐ CD 44‐Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis. Cancer Science. https://doi.org/10.1111/cas.70296

Vancouver

Nara A, Shimada S, Akiyama Y, Hatano M, Chino Y, Miyazawa S, et al. Targeting SPP 1‐ CD 44‐Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis. Cancer Science. 2025. doi:10.1111/cas.70296

BibTeX
@article{Nara2025,
  author = {Nara, Atsushi and Shimada, Shu and Akiyama, Yoshimitsu and Hatano, Megumi and Chino, Yusuke and Miyazawa, Suguru and Tamura, Hanako and Asano, Daisuke and Ishikawa, Yoshiya and Ueda, Hiroki and Watanabe, Shuichi and Katsuta, Eriko and Akahoshi, Keiichi and Ohashi, Kenichi and Tanabe, Minoru and Ban, Daisuke and Tanaka, Shinji},
  title = {Targeting SPP 1‐ CD 44‐Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.70296}
}
Kostenlos starten →